Suchergebnisse - "Souglakos, J."

PubPharm (138)

1

Three- versus six-month adjuvant FOLFOX or CAPOX for high-risk stage II and stage III colon cancer patients : the efficacy results of Hellenic Oncology Research Group (HORG) participation to the International Duration Evaluation of Adjuvant Chemotherapy (IDEA) project

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2019

von Souglakos, J. | Boukovinas, I. | Kakolyris, S. | +22

2

Association of BRCA1, ERCC1, RAP80, PKM2, RRM1, RRM2, TS, TSP1, and TXR1 mRNA expression levels between primary tumors and infiltrated regional lymph nodes in patients with resectable non-small cell lung cancer

enthalten in: The pharmacogenomics journal | 2019

von Tryfonidis, K. | Papadaki, C. | Assele, S. | +10

3

Predictive value of ATP7b, BRCA1, BRCA2, PARP1, UIMC1 (RAP80), HOXA9, DAXX, TXN (TRX1), THBS1 (TSP1) and PRR13 (TXR1) genes in patients with epithelial ovarian cancer who received platinum-taxane first-line therapy

enthalten in: The pharmacogenomics journal | 2017

von Pontikakis, S. | Papadaki, C. | Tzardi, M. | +11

4

P-028Analysis of KRAS and NRAS mutations in Greek patients with metastatic Colorectal Cancer (mCRC) on the registry of the Gastro-intestinal Cancer Study Group (GIC-SG)

enthalten in: Annals of oncology | 2016

von Souglakos, J. | Saridaki, Z. | Gouges, N. | +7

5

Predictive value of ATP7b, BRCA1, BRCA2, PARP1, UIMC1 (RAP80), HOXA9, DAXX, TXN (TRX1), THBS1 (TSP1) and PRR13 (TXR1) genes in patients with epithelial ovarian cancer who received platinum-taxane first-line therapy

enthalten in: The pharmacogenomics journal | 2016

von Pontikakis, S. | Papadaki, C. | Tzardi, M. | +11

6

Predictive value of ATP7b, BRCA1, BRCA2, PARP1, UIMC1 (RAP80), HOXA9, DAXX, TXN (TRX1), THBS1 (TSP1) and PRR13 (TXR1) genes in patients with epithelial ovarian cancer who received platinum-taxane first-line therapy

enthalten in: The pharmacogenomics journal | 2016

von Pontikakis, S. | Papadaki, C. | Tzardi, M. | +11

7

PKM2 as a biomarker for chemosensitivity to front-line platinum-based chemotherapy in patients with metastatic non-small-cell lung cancer

enthalten in: British journal of cancer | 2014

von Papadaki, C. | Sfakianaki, M. | Lagoudaki, E. | +9

8

PKM2 as a biomarker for chemosensitivity to front-line platinum-based chemotherapy in patients with metastatic non-small-cell lung cancer

enthalten in: The British journal of cancer | 2014

von Papadaki, C. | Sfakianaki, M. | Lagoudaki, E. | +9

9

Association of age with survival in patients with metastatic colorectal cancer : analysis from the ARCAD Clinical Trials Program

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2014

von Lieu, C. | Renfro, L. | de Gramont, A. | +72

10

Frontline treatment with gemcitabine, oxaliplatin and erlotinib for the treatment of advanced or metastatic pancreatic cancer : a multicenter phase II study of the Hellenic Oncology Research Group (HORG)

enthalten in: Cancer chemotherapy and pharmacology | 2014

von Katopodis, O. | Souglakos, J. | Stathopoulos, E. | +8

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[14]